Posts

British Columbia to Decriminalize Possession of All Drugs

British Columbia to Decriminalize Possession of Most Drugs

Those caught with under 2.5 grams of illicit drugs, including heroin and fentanyl, will not face jail time when the regulations go into effect.
Shutterstock

Psychedelic Medicine Has Institutional Buy-In & 4 More Catalyst Summit Takeaways

,
After leaving the Catalyst Summit, I am more confident than ever in the governmental and regulatory pathways for legal psychedelic medicine.
Psychedelic Business Spotlight - January 21

Psychedelic Business Spotlight – January 21

,
Catch up on some of the biggest psychedelic business developments that unfolded in the last week.
Health Canada Grants Special Access to Restricted Drugs for Psychedelic TherapyShutterstock

Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy

New amendment reverses a 2013 Health Canada policy that prevented "a letter of authorization for a new drug that is or that contains a restricted drug."
Shutterstock.com

Canada Reaches Psychedelic Milestone with First Legal Group Psilocybin Therapy Session

And the results, according to the participants, were nothing short of "profound."
MAPS Expands MDMA-Assisted Therapy for PTSD Trial Into CanadaShutterstock.com

MAPS Expands MDMA-Assisted Therapy for PTSD Trial Into Canada

Rick Doblin's organization partners with Numinus Wellness to manage the Canadian sites where therapists will be administering the psychedelic therapy.
University of Ottawa Offers Canada's First Psychedelic Studies Program

University of Ottawa Offers Canada’s First Psychedelic Studies Program

And since the classes are online, students can live anywhere in the world while taking Psychedelic and Spiritual Studies courses at the university.
Psychedelic Sector Reaches International Supply Chain Milestones

Psychedelic Sector Reaches International Supply Chain Milestones

Canadian psychedelics production company Red Light Holland announces largest legal sale and import of psilocybe truffles.
Canada Green Lights Country’s Third Clinical Psilocybin Study

Canada Green Lights Country’s Third Clinical Psilocybin Study

The trial will build on Diamond Therapeutic's previous animal research that demonstrated how non-hallucinogenic doses of psilocybin hold the potential to treat psychiatric disorders, including anxiety and depression.
Majority of Canadians Support Psilocybin-Assisted Therapy, According to New Poll

Majority of Canadians Support Psilocybin-Assisted Therapy, According to New Poll

As a result, the Canadian Psychedelic Association responds with a Memorandum of Regulatory Approval, which advises medicinal psilocybin therapy to be authorized in a safe and therapeutic environment.